Log in
NYSE:AVNS

Avanos Medical Stock Forecast, Price & News

$43.30
+0.30 (+0.70 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$42.62
Now: $43.30
$43.51
50-Day Range
$35.35
MA: $39.50
$43.34
52-Week Range
$19.46
Now: $43.30
$44.85
Volume101,768 shs
Average Volume264,548 shs
Market Capitalization$2.07 billion
P/E Ratio149.31
Dividend YieldN/A
Beta1.01
Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Its product portfolio includes digestive health products, including enteral feeding tubes and solutions; respiratory health products, such as closed airway suction systems and oral care kits; and acute pain products comprising surgical pain pumps, and cold and compression therapy systems, as well as interventional pain management solutions that include minimally invasive interventional pain therapies. The company sells its products under the MIC-KEY, CORPAK, NEOMED, BALLARD, MICROCUFF, ENDOCLEAR, ON-Q, AMBIT, GAME READY, and COOLIEF brand names. It markets its products directly to hospitals and other healthcare providers, and through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Read More
Avanos Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.1Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.35 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone844-428-2667
Employees4,700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$697.60 million
Cash Flow$1.84 per share
Book Value$26.97 per share

Profitability

Net Income$-45,900,000.00

Miscellaneous

Market Cap$2.07 billion
Next Earnings Date2/23/2021 (Estimated)
OptionableOptionable
$43.30
+0.30 (+0.70 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AVNS News and Ratings via Email

Sign-up to receive the latest news and ratings for AVNS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Avanos Medical (NYSE:AVNS) Frequently Asked Questions

How has Avanos Medical's stock been impacted by Coronavirus (COVID-19)?

Avanos Medical's stock was trading at $29.01 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AVNS stock has increased by 49.3% and is now trading at $43.30.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Avanos Medical?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Avanos Medical
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Avanos Medical?

Wall Street analysts have given Avanos Medical a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Avanos Medical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Avanos Medical's next earnings date?

Avanos Medical is scheduled to release its next quarterly earnings announcement on Tuesday, February 23rd 2021.
View our earnings forecast for Avanos Medical
.

How were Avanos Medical's earnings last quarter?

Avanos Medical, Inc. (NYSE:AVNS) posted its quarterly earnings results on Tuesday, November, 3rd. The company reported $0.21 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.10 by $0.11. The company had revenue of $186 million for the quarter, compared to analysts' expectations of $165.87 million. Avanos Medical had a return on equity of 3.20% and a net margin of 1.93%. The business's revenue for the quarter was up 8.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.30 EPS.
View Avanos Medical's earnings history
.

What price target have analysts set for AVNS?

5 equities research analysts have issued twelve-month price targets for Avanos Medical's stock. Their forecasts range from $30.00 to $47.00. On average, they anticipate Avanos Medical's stock price to reach $35.00 in the next year. This suggests that the stock has a possible downside of 19.2%.
View analysts' price targets for Avanos Medical
.

Are investors shorting Avanos Medical?

Avanos Medical saw a drop in short interest during the month of October. As of October 15th, there was short interest totaling 1,960,000 shares, a drop of 17.6% from the September 30th total of 2,380,000 shares. Based on an average daily volume of 245,100 shares, the days-to-cover ratio is presently 8.0 days. Currently, 4.2% of the company's stock are sold short.
View Avanos Medical's Short Interest
.

Who are some of Avanos Medical's key competitors?

What other stocks do shareholders of Avanos Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly-Clark (KMB), CVS Health (CVS), Honeywell International (HON), Pfizer (PFE), The Procter & Gamble (PG), Johnson & Johnson (JNJ), Raytheon Technologies (RTX), AT&T (T), Abbott Laboratories (ABT) and Alibaba Group (BABA).

Who are Avanos Medical's key executives?

Avanos Medical's management team includes the following people:
  • Mr. Joseph F. Woody, CEO & Director (Age 54, Pay $1.06M)
  • Mr. John W. Wesley, Sr. VP (Age 61, Pay $436.62k)
  • Mr. Warren J. MacHan, Sr. VP of Bus. Strategy (Age 54, Pay $378.86k)
  • Mr. Arjun Ranjan Sarker, Sr. VP of International (Age 54, Pay $584.63k)
  • Mr. David Edward Ball, Sr. VP of Global Supply Chain & Procurement (Age 61, Pay $792.3k)
  • Mr. Michael C. Greiner, Sr. VP & CFO (Age 47)
  • Mr. Renato Negro, VP, Controller & Chief Accounting Officer
  • Mr. David Crawford, VP of FP&A and Investor Relations and Treasurer
  • Mr. S. Ross Mansbach, Sr. VP, Interim Gen. Counsel & Corp. Sec.
  • Ms. Michelle Scharfenberg, Sr. VP and Chief Ethics & Compliance Officer

What is Avanos Medical's stock symbol?

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

Who are Avanos Medical's major shareholders?

Avanos Medical's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (10.76%), Champlain Investment Partners LLC (7.07%), Victory Capital Management Inc. (4.30%), State Street Corp (3.60%), Confluence Investment Management LLC (1.07%) and Neuberger Berman Group LLC (1.03%). Company insiders that own Avanos Medical stock include Gary Blackford and Joseph Fralin Woody.
View institutional ownership trends for Avanos Medical
.

Which institutional investors are selling Avanos Medical stock?

AVNS stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., State Street Corp, Employees Retirement System of Texas, Confluence Investment Management LLC, Federated Hermes Inc., Morgan Stanley, Charles Schwab Investment Management Inc., and Neuberger Berman Group LLC.
View insider buying and selling activity for Avanos Medical
.

Which institutional investors are buying Avanos Medical stock?

AVNS stock was purchased by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Assenagon Asset Management S.A., JPMorgan Chase & Co., Millrace Asset Group Inc., Great West Life Assurance Co. Can, Champlain Investment Partners LLC, Pacer Advisors Inc., and Sei Investments Co.. Company insiders that have bought Avanos Medical stock in the last two years include Gary Blackford, and Joseph Fralin Woody.
View insider buying and selling activity for Avanos Medical
.

How do I buy shares of Avanos Medical?

Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Avanos Medical's stock price today?

One share of AVNS stock can currently be purchased for approximately $43.30.

How big of a company is Avanos Medical?

Avanos Medical has a market capitalization of $2.07 billion and generates $697.60 million in revenue each year. The company earns $-45,900,000.00 in net income (profit) each year or $1.07 on an earnings per share basis. Avanos Medical employs 4,700 workers across the globe.

What is Avanos Medical's official website?

The official website for Avanos Medical is avanos.com.

How can I contact Avanos Medical?

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company can be reached via phone at 844-428-2667 or via email at [email protected]

This page was last updated on 11/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.